
Xilio Therapeutics, Inc.
Xilio Therapeutics, Inc. (XLO)
WebsitePrice
Market cap
Next catalystExpected 1H 2027Efarindodekin alfa — monotherapy · Phase 2 dataSEC filing ↗
Cash
Chart & Events
Core Clinical
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Representative pipeline applications
Clinical
Upcoming clinical milestones
Other pipelines
PreINDP1P2P3FilingApproved